These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 7764758)

  • 1. Recombinant microbial ADP-ribosylating toxins of Bordetella pertussis, Vibrio cholerae, and enterotoxigenic Escherichia coli: structure, function, and toxoid vaccine development.
    Burnette WN; Cieplak W; Kaslow HR; Rappuoli R; Tuomanen EI
    Bioprocess Technol; 1994; 19():185-203. PubMed ID: 7764758
    [No Abstract]   [Full Text] [Related]  

  • 2. AB5 ADP-ribosylating toxins: comparative anatomy and physiology.
    Burnette WN
    Structure; 1994 Mar; 2(3):151-8. PubMed ID: 8069630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic detoxification of bacterial toxins.
    Pizza M; Fontana MR; Scarlato V; Rappuoli R
    Methods Mol Med; 2003; 87():133-52. PubMed ID: 12958454
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacterial ADP-ribosylating toxins: form, function, and recombinant vaccine development.
    Burnette WN
    Behring Inst Mitt; 1997 Feb; (98):434-41. PubMed ID: 9382767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins.
    Domenighini M; Magagnoli C; Pizza M; Rappuoli R
    Mol Microbiol; 1994 Oct; 14(1):41-50. PubMed ID: 7830559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylating toxins.
    Passador L; Iglewski W
    Methods Enzymol; 1994; 235():617-31. PubMed ID: 8057931
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial protein toxins with latent ADP-ribosyl transferases activities.
    Lai CY
    Adv Enzymol Relat Areas Mol Biol; 1986; 58():99-140. PubMed ID: 3012972
    [No Abstract]   [Full Text] [Related]  

  • 8. ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.
    Moss J; Vaughan M
    Adv Enzymol Relat Areas Mol Biol; 1988; 61():303-79. PubMed ID: 3128060
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of recombinant Bordetella pertussis serotype 2 fimbriae in Bordetella parapertussis and Bordetella bronchiseptica: utility of Escherichia coli gene expression signals.
    Walker MJ; Guzmán CA; Rohde M; Timmis KN
    Infect Immun; 1991 May; 59(5):1739-46. PubMed ID: 1708358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-ribosylating microbial toxins.
    Foster JW; Kinney DM
    Crit Rev Microbiol; 1985; 11(4):273-98. PubMed ID: 2859967
    [No Abstract]   [Full Text] [Related]  

  • 11. The chromosomal nature of LT-II enterotoxins solved: a lambdoid prophage encodes both LT-II and one of two novel pertussis-toxin-like toxin family members in type II enterotoxigenic Escherichia coli.
    Jobling MG
    Pathog Dis; 2016 Apr; 74(3):. PubMed ID: 26755534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxin ADP-ribosyltransferases that act on adenylate cyclase systems.
    Moss J; Vaughan M
    Methods Enzymol; 1984; 106():411-8. PubMed ID: 6092833
    [No Abstract]   [Full Text] [Related]  

  • 13. Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen.
    Lipscombe M; Charles IG; Roberts M; Dougan G; Tite J; Fairweather NF
    Mol Microbiol; 1991 Jun; 5(6):1385-92. PubMed ID: 1724057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enterotoxigenic Escherichia coli causing cholerogenic syndrome during an interepidemic period of cholera in North India.
    Taneja N; Rao P; Rao DS; Singh M; Sharma M
    Jpn J Infect Dis; 2006 Aug; 59(4):245-8. PubMed ID: 16936343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bvg accessory factor (Baf) enhances pertussis toxin expression in Escherichia coli and is essential for Bordetella pertussis viability.
    Wood GE; Friedman RL
    FEMS Microbiol Lett; 2000 Dec; 193(1):25-30. PubMed ID: 11094274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer modelling of the NAD binding site of ADP-ribosylating toxins: active-site structure and mechanism of NAD binding.
    Domenighini M; Montecucco C; Ripka WC; Rappuoli R
    Mol Microbiol; 1991 Jan; 5(1):23-31. PubMed ID: 1901617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pleiotropic secretion mutant of Aeromonas hydrophila is unable to secrete heterologously expressed E. coli enterotoxin: implication for common mechanisms of protein secretion.
    Yu J; Hirst TR
    Biochem Soc Trans; 1995 Feb; 23(1):34S. PubMed ID: 7758745
    [No Abstract]   [Full Text] [Related]  

  • 18. Structural biology and structure-based inhibitor design of cholera toxin and heat-labile enterotoxin.
    Fan E; O'Neal CJ; Mitchell DD; Robien MA; Zhang Z; Pickens JC; Tan XJ; Korotkov K; Roach C; Krumm B; Verlinde CL; Merritt EA; Hol WG
    Int J Med Microbiol; 2004 Oct; 294(4):217-23. PubMed ID: 15532979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cellular and acellular anti-pertussis vaccines].
    Locht C
    Ann Pharm Fr; 2001 May; 59(3):198-205. PubMed ID: 11427821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Bordetella pertussis regulatory factor required for transcription of the pertussis toxin operon in Escherichia coli.
    DeShazer D; Wood GE; Friedman RL
    J Bacteriol; 1995 Jul; 177(13):3801-7. PubMed ID: 7601846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.